News Pharmaspectra appoints UDG’s Jez Moulding as CEO Jez Moulding has moved from UDG and its Ashfield business to join and lead medical science information company Pharmaspectra.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
